Krystal Biotech Announces Pricing of Upsized Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Werewolf Therapeutics sells platform assets to EMD Serono for $33M
Krystal Biotech (KRYS) IPO Opens Modestly Higher
September 20, 2017 11:31 AM EDTToday's IPO for Krystal Biotech (NASDAQ: KRYS) opened for trading at $10.50 after pricing 3,960,000 shares of common stock at a price to the public of $10.00 per share.
In addition, Krystal has granted the underwriters a 30-day option to purchase up to an additional 594,000... More
